glp-1 agonists cardiovascular diseases Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action GLP-1 Receptor Agonists in Heart

Zu den gngigen Medikamenten gehren: Semaglutid (Ozempic, Wegovy) Liraglutid (Saxenda) Dulaglutid (Trulicity) Exenatid (Byetta) Tirzepatid (Mounjaro) dualer Agonist, wirkt an GLP1 und GIPRezeptoren Die meisten GLP-1-Agonisten werden tglich oder wchentlich in Form einer Abnehmspritze als Injektion unter die Haut verabreicht

Eur J Endocrinol (2019) 181(2):16171

First, we emulated two cardiovascular outcome trials, SUSTAIN-6 (semaglutide versus sitagliptin as placebo proxy) and SURPASS-CVOT (tirzepatide versus dulaglutide), to benchmark and critically evaluate our design, data and analytic framework

It is whether patients can access it, afford it, tolerate it, and receive the counseling needed for safe, sustainable use

DPP-4 inhibitors: Focus on safety